News

A study established new neighborhood characteristics that lead to higher death rates in children with leukemia that can serve ...
A first-of-its-kind study tested the safety of psilocybin on patients with mild to moderate Parkinson’s disease and found ...
UCSF Benioff Children's Hospitals in Oakland and San Francisco celebrated prom events for their teenage patients with casino ...
UCSF Health intends to continue regular operations, including emergency care, and expects to be able to maintain the majority ...
Researcher and campus leader Atul Butte, MD, PhD, has been recognized for his outstanding career in the computational and ...
Neurosurgery experts from UCSF Health will present new research and clinical findings at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Boston, April 25-28.
UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...